Flaisher-Grinberg S, Tsai H C, Feng X, Wei L N
Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455, USA; Department of Neurosurgery, Chang-Gung Memorial Hospital and University, Tao-Yuan, Taiwan, ROC.
Brain Behav Immun. 2014 Aug;40:226-34. doi: 10.1016/j.bbi.2014.03.019. Epub 2014 Apr 13.
Receptor-interacting protein (RIP140) is a transcription co-regulator highly expressed in macrophages to regulate inflammatory and metabolic processes. However, its implication in neurological, cognitive and emotional conditions, and the cellular systems relevant to its biological activity within the central nervous system are currently less clear. A transgenic mouse line with macrophage-specific knockdown of RIP140 was generated (MΦRIPKD mice) and brain-region specific RIP140 knockdown efficiency evaluated. Mice were subjected to a battery of tests, designed to evaluate multiple behavioral domains at naïve or following site-specific RIP140 re-expression. Gene expression analysis assessed TNF-α, IL-1β, TGF-1β, IL1-RA and neuropeptide Y (NPY) expression, and in vitro studies examined the effects of macrophage's RIP140 on astrocytes' NPY production. We found that RIP140 expression was dramatically reduced in macrophages within the ventromedial hypothalamus (VMH) and the cingulate cortex of MΦRIPKD mice. These animals exhibited increased anxiety- and depressive-like behaviors. VMH-targeted RIP140 re-expression in MΦRIPKD mice reversed its depressive- but not its anxiety-like phenotype. Analysis of specific neurochemical changes revealed reduced astrocytic-NPY expression within the hypothalamus of MΦRIPKD mice, and in vitro analysis confirmed that conditioned medium of RIP140-silnenced macrophage culture could no longer stimulate NPY production from astrocytes. The current study revealed an emotional regulatory function of macrophage-derived RIP140 in the VMH, and secondary dysregulation of NPY within hypothalamic astrocyte population, which might be associated with the observed behavioral phenotype of MΦRIPKD mice. This study highlights RIP140 as a novel target for the development of potential therapeutic and intervention strategies for emotional regulation disorders.
受体相互作用蛋白(RIP140)是一种转录共调节因子,在巨噬细胞中高度表达,以调节炎症和代谢过程。然而,其在神经、认知和情绪状况中的作用,以及与其在中枢神经系统内的生物活性相关的细胞系统,目前尚不清楚。我们构建了一种巨噬细胞特异性敲低RIP140的转基因小鼠品系(MΦRIPKD小鼠),并评估了脑区特异性RIP140的敲低效率。对小鼠进行了一系列测试,旨在评估其在未处理时或在特定部位RIP140重新表达后的多种行为领域。基因表达分析评估了肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、转化生长因子-1β(TGF-1β)、白细胞介素1受体拮抗剂(IL1-RA)和神经肽Y(NPY)的表达,体外研究则检测了巨噬细胞的RIP140对星形胶质细胞NPY产生的影响。我们发现,在MΦRIPKD小鼠的腹内侧下丘脑(VMH)和扣带回皮质中的巨噬细胞中,RIP140的表达显著降低。这些动物表现出焦虑样和抑郁样行为增加。在MΦRIPKD小鼠中,VMH靶向的RIP140重新表达逆转了其抑郁样表型,但未逆转焦虑样表型。对特定神经化学变化的分析显示,MΦRIPKD小鼠下丘脑内星形胶质细胞NPY的表达降低,体外分析证实,RIP140沉默的巨噬细胞培养条件培养基不再能刺激星形胶质细胞产生NPY。当前研究揭示了巨噬细胞衍生的RIP140在VMH中的情绪调节功能,以及下丘脑星形胶质细胞群体中NPY的继发性失调,这可能与观察到的MΦRIPKD小鼠的行为表型有关。这项研究突出了RIP140作为开发情绪调节障碍潜在治疗和干预策略的新靶点。